BIRC3 and cancer: This work described the involvement of the TLR4/NF-κB pathway activation which led to the overexpression of BIRC3 (Baculoviral IAP Repeat Containing 3), a member of apoptosis’ inhibitor proteins known to be involved in the chemoresistance of several cancers [42,43].